This is not a minor upgrade
Phase 1 of Clinical Trials : Objective: To assess the safety, tolerability, and initial efficacy of the drug
Food Supplements (England) Regulations 2003 (SI 2003/1387)
Retatrutide is a new drug being investigated for obesity and type 2 diabetes
Reviewers typically look for an HbA1c at or above 7.0 percent for type 2 diabetes coverage, a BMI of 27 or higher with a comorbidity or 30 or higher standalone, a documented trial of metformin or another agent, and cardiovascular history such as coronary artery disease, stroke, or heart failure
Monitor blood glucose levels more frequently, check ketones if advised by your healthcare team, and consider temporarily adjusting other diabetes medications (particularly insulin, metformin or SGLT2 inhibitors) after seeking clinical advice if you're unable to eat or drink normally